Low-Dose Naltrexone appears stable for long-term MS control
Posted: Fri Oct 14, 2016 2:10 am
Low dose naltrexone (LDN) appears to be safe for patients with multiple sclerosis even when taken long term. A paper describing the research, authored by Michael Ludwig of the Department of Neural and Behavioral Sciences at the Pennsylvania University College of Medicine, and colleagues, was published recently in the Multiple Sclerosis Journal -- Experimental, Translational and Clinical...Read more - http://www.ms-uk.org/low-dose-naltrexon ... rol-141016